Cerecin
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Cerecin sits in the top decile of US sponsors by registered trial count (#1,226 of 15,751 sponsors by registered trial count).
Cerecin: 11 sponsored US clinical trials, none currently recruiting.
Cerecin sponsors 11 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 11 completed. 0 of these trials are in Phase 3-4 (later-stage) and 10 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 3 trials.
Top-decile sponsor footprint
Cerecin ranks in the top decile of sponsors by registered trial count (#1,226 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Indexed trials (enrollment closed)
11 total, page 1 of 1
A Phase 1, Two-part, Randomized Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Liquid Formulation of Tricaprilin and Matching Placebo in Healthy Subjects
NCT05408780
Study to Compare the Pharmacokinetics of Daily Administration of Tricaprilin on Ketone Body Production
NCT04268953
Taste-masking Study for Tricaprilin in Sensory Panelists
NCT03628352
Study to Compare the Pharmacokinetics of AC 1202 and Two Doses of AC-SD-01 on Ketone Body Production
NCT03063645
Evaluation of PK of AC-1204 Mixed in Water, AC-1202 Mixed in Water, and AC-1202 Mixed in Ensure® on Ketone Body Production
NCT02959710
Evaluation of PK of Caprylic Triglyceride Oil, AC-1202, AC-1204, and Axona on Ketone Body Production
NCT02833012
Evaluation of PK of AC1204 v Caprylic Triglyceride Oil Incl Food Effect on Ketone Body Production
NCT02747602
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
NCT01741194
Safety of Three Formulations of Ketasyn Administered for 14 Days in Healthy Elderly
NCT00660088
Tricaprilin In Age-Associated Memory Impairment
NCT00355550
Tricaprilin in Mild to Moderate Alzheimer's Disease
NCT00142805
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 7 |
| Phase 2 | 3 |
Therapeutic Areas
How the Cerecin early-phase archive is shaped
11 indexed studies, none listed as recruiting (0% open); 11 completed (100%).
Phase mix: 0 late (III/IV) vs 10 early (I/II) (early-phase heavy).
Top condition: Healthy (3 trials), 1 other listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.